Literature DB >> 12466280

The cytotoxic activity of ribosome-inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities.

Shveta Bagga1, Divya Seth, Janendra K Batra.   

Abstract

Saporin-6 produced by the plant Saponaria officinalis belongs to the family of single chain ribosome-inactivating proteins. It potently inhibits protein synthesis in eukaryotic cells, by cleaving the N-glycosidic bond of a specific adenine in 28 S rRNA, which results in the cell death. Saporin-6 has also been shown to be active on DNA and induces apoptosis. In the current study, we have investigated the roles of rRNA depurination and the activity of saporin-6 on genomic DNA in its cytotoxic activity. The role of putative active site residues, Tyr(72), Tyr(120), Glu(176), Arg(179), and Trp(208), and two invariant residues, Tyr(16) and Arg(24), proposed to be important for structural stability of saporin-6, has been investigated in its catalytic and cytotoxic activity. These residues were mutated to alanine to generate seven mutants, Y16A, R24A, Y72A, Y120A, E176A, R179A, and W208A. We show that for the RNA N-glycosidase activity of saporin-6, residues Tyr(16), Tyr(72), and Arg(179) are absolutely critical; Tyr(120) and Glu(176) can be partially dispensed with, whereas Trp(208) and Arg(24) do not appear to be involved in this activity. The residues Tyr(72), Tyr(120), Glu(176), Arg(179), and Trp(208) were found to be essential for the genomic DNA fragmentation activity, whereas residues Tyr(16) and Arg(24) do not appear to be required for the DNA fragmentation. The study shows that saporin-6 possesses two catalytic activities, namely RNA N-glycosidase and genomic DNA fragmentation activity, and for its complete cytotoxic activity both activities are required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466280     DOI: 10.1074/jbc.M207389200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  The differential catalytic activity of ribosome-inactivating proteins saporin 5 and 6 is due to a single substitution at position 162.

Authors:  Paroma Ghosh; Janendra K Batra
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

2.  Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice.

Authors:  Chunyan Gao; Jocelyn A Schroeder; Feng Xue; Weiqing Jing; Yuanhua Cai; Amelia Scheck; Saravanan Subramaniam; Sridhar Rao; Hartmut Weiler; Agnieszka Czechowicz; Qizhen Shi
Journal:  Blood Adv       Date:  2019-09-24

3.  Riproximin modulates multiple signaling cascades leading to cytostatic and apoptotic effects in human breast cancer cells.

Authors:  Asim Pervaiz; Michael Zepp; Hassan Adwan; Martin R Berger
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-12       Impact factor: 4.553

4.  Selective formation of covalent protein heterodimers with an unnatural amino acid.

Authors:  Benjamin M Hutchins; Stephanie A Kazane; Karin Staflin; Jane S Forsyth; Brunhilde Felding-Habermann; Vaughn V Smider; Peter G Schultz
Journal:  Chem Biol       Date:  2011-03-25

5.  Expression and purification of cysteine introduced recombinant saporin.

Authors:  Emine Günhan; Mimi Swe; Mine Palazoglu; John C Voss; Leo M Chalupa
Journal:  Protein Expr Purif       Date:  2007-11-19       Impact factor: 1.650

6.  An anti-CD103 immunotoxin promotes long-term survival of pancreatic islet allografts.

Authors:  L Zhang; S D Moffatt-Bruce; A A Gaughan; J-J Wang; A Rajab; G A Hadley
Journal:  Am J Transplant       Date:  2009-07-23       Impact factor: 8.086

Review 7.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

8.  Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.

Authors:  Tracy R Daniels-Wells; Gustavo Helguera; José A Rodríguez; Lai Sum Leoh; Michael A Erb; Graciel Diamante; David Casero; Matteo Pellegrini; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  Toxicol In Vitro       Date:  2012-10-17       Impact factor: 3.500

Review 9.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 10.  Ribosome-inactivating proteins: from plant defense to tumor attack.

Authors:  Maddalena de Virgilio; Alessio Lombardi; Rocco Caliandro; Maria Serena Fabbrini
Journal:  Toxins (Basel)       Date:  2010-11-10       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.